Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

NCT01990118 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

106

Enrollment

OTHER_GOV

Sponsor class

Conditions

End Stage Renal Failure

Interventions

DRUG: Neoral
DRUG: Gengraf® capsule containing 25mg or 100mg cyclosporine

Sponsor

Penang Hospital, Malaysia